Sciwind Biosciences partners with Pfizer China to commercialise Biased GLP-1 in China in $495 M deal - BioSpectrum Asia

2026-02-24 - 06:43

Sciwind Biosciences partners with Pfizer China to commercialise Biased GLP-1 in China in $495 M deal BioSpectrum Asia